Use the toggle to switch between the simple overview and the professional reference content.

Pantothenic Acid (Vitamin B5)

Consumer Guide

Plain-English information for everyday use

1. What Is Vitamin B5?

Key Takeaway

Vitamin B5 — pantothenic acid — is a water-soluble vitamin your body needs every day to turn food into energy and make stress hormones; it's in almost every food, so true shortage is rare.

Vitamin B5, also called pantothenic acid, is a water-soluble B-complex vitamin. The name comes from the Greek word pantothen, meaning "from everywhere" — because this vitamin really is found in nearly every food. Williams RJ et al. J Am Chem Soc. 1933;55(7):2912-2927. Original isolation paper naming pantothenic acid. Open Source ↗

Your body needs B5 to make coenzyme A, a small molecule that sits at the center of energy production. Coenzyme A helps your cells turn carbohydrates, fats, and proteins into the energy you actually use. It's also needed to make stress hormones, certain neurotransmitters, and the fats that build your skin barrier. NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals. Open Source ↗

B5 is an essential nutrient — your body can't make it on its own, so you have to get it from food (or a supplement). Small amounts are produced by gut bacteria, but nowhere near enough to meet daily needs. Sanvictores T, Chauhan S. StatPearls: Vitamin B5 (Pantothenic Acid). NBK563233. Open Source ↗

You'll see B5 on supplement labels in several forms: calcium pantothenate (the most common), pantethine (a different form studied for cholesterol), and panthenol (the form in skin creams). They are related but not identical — they behave differently in the body, which matters for some uses. NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals. Open Source ↗

Key Highlights

Water-soluble B-complex vitamin (Vitamin B5)
Found in almost every food — true shortage is rare
Required to make coenzyme A — central to energy production
Supports stress hormone production and skin barrier health
Essential — must come from food or supplements
Best food sources: liver, fish, eggs, mushrooms, avocado, sunflower seeds, whole grains

2. Signs You May Be Running Low

Key Takeaway

True B5 shortage is rare because the vitamin is in nearly every food, but it can show as fatigue, headache, irritability, sleep changes, or burning sensations in the feet — none specific, so see your provider.

Severe vitamin B5 deficiency is essentially unknown in well-fed populations because the vitamin is so widely distributed in foods. When low intake does happen — usually only in severe malnutrition, restrictive eating patterns, or specific medical conditions — people may notice: NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals — Deficiency section. Open Source ↗

Fatigue or low energy that doesn't lift with rest
Headaches
Irritability or restlessness
Sleep changes or difficulty falling asleep
Nausea or stomach discomfort
Tingling, numbness, or burning sensations in the feet (the classic historical sign called "burning feet syndrome")
Muscle cramps

These signs can have many different causes — they're not specific to vitamin B5 alone. Always speak with your healthcare provider before assuming any single nutrient is the cause.

3. Who Should Be Careful or Avoid

Key Takeaway

Talk to your healthcare provider before starting B5 if you take blood thinners, have an upcoming procedure, take high-dose biotin, are pregnant or breastfeeding, or have a known allergy.

Who Should Talk to a Healthcare Provider First

Vitamin B5 has one of the cleanest safety profiles of any vitamin, but a few situations call for a conversation with your provider before starting or changing your routine:

People taking blood-thinning medications — One specific form of B5, pantethine, has a mild blood-thinning effect. If you take warfarin, aspirin, clopidogrel, or similar medications, tell your provider before starting pantethine. Naumann S et al. PMC11013948. 2024. Open Source ↗
People scheduled for surgery within 2 weeks — Stop pantethine and tell the surgical team. Regular calcium pantothenate (the basic form in multivitamins) does not require this precaution.
Elderly adults taking high-dose biotin — A rare case report described a serious reaction in an older person taking high-dose B5 plus high-dose biotin together. If you take large amounts of both, talk to your provider. Debourdeau PM et al. Ann Pharmacother. 2001;35(4):424-426. PMID 11302404. Open Source ↗
People with PKAN — A very rare genetic condition. High-dose pantothenic acid use must be coordinated by a pediatric neurology or NBIA specialist. Don't self-adjust the dose.
Pregnant or breastfeeding — Standard daily intake during pregnancy (6 mg/day in the US, 5 mg/day in Europe) and breastfeeding (7 mg/day) is well established and safe. Higher therapeutic doses during pregnancy and breastfeeding should be discussed with your provider. Institute of Medicine. Dietary Reference Intakes 1998. Open Source ↗
People with known allergy — to pantothenic acid, pantethine, dexpanthenol, or any product containing them. Avoid all forms.

Timing Notes for Other Supplements and Medications

Tetracycline antibiotics — Standard B-complex guidance: take any B-complex supplement (which includes B5) at least 2 hours apart from tetracycline.
High-dose biotin or alpha-lipoic acid — These share an absorption pathway with B5 in the gut. If you take large amounts of all three, separate them by 2-4 hours to avoid mutual interference.

4. How to Get the Best Results

Key Takeaway

Take B5 with food to settle the stomach; the standard adult daily intake is 5 mg, and the supplement form that matches your goal matters more than the brand.

Daily Intake

The adequate intake (AI) for adults is 5 mg per day in both the US and Europe. The FDA Daily Value on supplement labels is also 5 mg. Institute of Medicine. Dietary Reference Intakes 1998. Open Source ↗

Adults (general): 5 mg/day
Pregnancy: 6 mg/day (US) or 5 mg/day (Europe)
Breastfeeding: 7 mg/day
Children (varies by age): 2 mg (age 1–3) up to 5 mg (teen)

When and How to Take It

Take with food

Especially at higher doses, taking B5 with a meal reduces the chance of mild stomach upset. Sanvictores T, Chauhan S. StatPearls: Vitamin B5 (Pantothenic Acid). 2026. Open Source ↗

Divide higher doses

For high-dose protocols (such as 2,200 mg/day for acne research, or 900 mg/day pantethine for cholesterol research), divide the daily total across 2-3 meals rather than taking all at once. This improves tolerability and matches how the clinical trials dosed it.

Separate from high-dose biotin or alpha-lipoic acid

If you take large amounts of biotin or alpha-lipoic acid alongside B5, separate them by 2–4 hours. They share the same gut transport pathway and can compete for absorption.

No taper needed when stopping

B5 doesn't cause withdrawal effects. You can stop at any time without tapering. If you were using pantethine for cholesterol, your lipid numbers will gradually drift back to baseline over a few weeks.

Choosing the Right Form for Your Goal

For general nutrition

Calcium pantothenate is the everyday form found in multivitamins and B-complex products. Good general-purpose choice.

For cholesterol research-supported use

Pantethine is the form studied in cholesterol trials. Calcium pantothenate does not produce the same effect — they behave differently in the body.

For skin application

Topical panthenol or dexpanthenol creams (such as Bepanthen) are the right form for skin care. Oral B5 is not used topically.

Time to See an Effect

For most uses of B5 you wouldn't expect to "feel" anything specific — it just supports normal background metabolism. For specific research-supported uses:

Pantethine for cholesterol — measurable LDL-C changes around 8 weeks; full effect at 16 weeks. Evans M et al. Vasc Health Risk Manag. 2014;10:89-100. Open Source ↗
High-dose B5 for acne (Yang 2014 protocol) — 12-week protocol; possible early skin texture changes within 2–3 weeks.
Topical panthenol cream — subjective improvement within days; epithelial repair 1–2 weeks; full course typically 2–4 weeks.

5. Side Effects to Know About

Key Takeaway

Vitamin B5 has one of the safest profiles of any vitamin — the Institute of Medicine has not set an upper limit because there isn't enough evidence of harm to define one; side effects when they occur are usually mild GI upset at very high doses.

Vitamin B5 has an exceptionally clean safety profile. The Institute of Medicine reviewed the evidence and concluded there wasn't enough data on harm to set a tolerable upper intake level (UL). European regulators reached the same conclusion. Institute of Medicine. Dietary Reference Intakes 1998. Open Source ↗

Mild Effects (Usually Only at Very High Doses)

Diarrhea or loose stools — most often above 10 grams per day
Stomach discomfort or nausea
Mild headache (uncommon, idiosyncratic)
Skin reactions to topical panthenol creams (rare contact dermatitis)

Pantethine-Specific

The pantethine form, specifically, has a mild antiplatelet (blood-thinning) effect at therapeutic doses. This isn't a problem on its own, but tell your healthcare provider if you take warfarin, aspirin, or clopidogrel, or if a procedure is scheduled. Naumann S et al. PMC11013948. 2024. Open Source ↗

One Rare Serious Case to Know About

A single older case report described an elderly patient taking high-dose pantothenic acid plus high-dose biotin together who developed a serious reaction (eosinophilic pleuropericardial effusion). The reaction resolved when both supplements were stopped. This is a single case from 2001 and has not been replicated, but it's worth knowing about for older adults considering high-dose combinations of both vitamins. Debourdeau PM et al. Ann Pharmacother. 2001;35(4):424-426. PMID 11302404. Open Source ↗

Withdrawal or Rebound

None documented. The major safety-monitoring databases (US FDA FAERS, European EudraVigilance, WHO VigiBase) show no signal for withdrawal or rebound effects from any B5 form. No taper is required when stopping.

6. What Research Suggests

Key Takeaway

The evidence is strongest for ordinary dietary needs and modest for pantethine (a different form) on cholesterol; the high-dose acne protocol has one positive trial, while athletic-performance claims are not supported.

Here's an honest look at where the science stands for the most-studied uses of vitamin B5. The Three States Rule applies: supportive findings, null findings, and any adverse findings all surface — the goal is the actual picture, not the marketable one.

Evidence: Strong

Daily dietary need (5 mg/day)

The role of B5 as an essential nutrient is established by decades of research, including the original 1933 isolation by Roger Williams and Fritz Lipmann's Nobel-Prize-winning discovery of coenzyme A in the 1950s. The daily intake of 5 mg is set by the US Institute of Medicine and confirmed by the European Food Safety Authority.

Institute of Medicine. Dietary Reference Intakes 1998. Open Source ↗

Evidence: Moderate (pantethine form only)

Cholesterol — pantethine 600–900 mg/day for 16 weeks

The most rigorous modern trial (Evans 2014, triple-blind, placebo-controlled) found a modest LDL-C reduction in adults at low-to-moderate cardiovascular risk. The between-group statistical significance was reached at week 8 (P=0.027) and the full effect at week 16 (P=0.010). The effect size — about 3–4% LDL reduction — is meaningful but smaller than standard statin therapy. Calcium pantothenate (regular B5) does not produce the same effect; the cholesterol effect comes specifically from pantethine.

Evans M et al. Vasc Health Risk Manag. 2014;10:89-100. Open Source ↗ McRae MP. Nutr Res. 2005;25(4):319-333. Pooled analysis of 28 studies. Open Source ↗

Evidence: Limited — one positive trial

Acne — high-dose B5 (2.2 g/day for 12 weeks)

One placebo-controlled trial (Yang 2014, n=41 evaluable) found a meaningful reduction in lesion counts at week 12 (P=0.0197). This is one positive study that has not been independently replicated. The result is promising but should be viewed as a signal, not settled science.

Yang M et al. Dermatol Ther (Heidelb). 2014;4(1):93-101. Open Source ↗

Evidence: Moderate (topical)

Skin care creams — topical panthenol / dexpanthenol

Multiple small-to-medium clinical trials document modest benefit for wound healing, mild atopic dermatitis, and post-procedure soothing. An expert safety panel reviewed cosmetic use and concluded panthenol-containing products are safe as used.

Scott LN et al. Int J Toxicol. 2022;41(2_suppl):77S-105S. CIR Expert Panel safety assessment. Open Source ↗

Evidence: Limited / Anecdotal

PKAN — very rare genetic condition

Specialist consensus supports trying high-dose pantothenic acid (titrated from 250 mg to 2–5 g/day) in atypical adult-onset PKAN. This is anecdote-based without controlled-trial confirmation. An experimental drug designed to bypass the genetic defect (fosmetpantotenate) failed its Phase 3 trial in 2019. Specialist coordination is essential.

Retrophin (now Travere). Press release Aug 22, 2019. FORT Phase 3 fosmetpantotenate failed primary endpoint. Open Source ↗

Evidence: Not supported (studied and null)

Athletic performance

Several studies have examined whether extra B5 improves athletic performance in well-trained athletes. The research does not support an improvement. Marketing claims about B5 for sports performance are not supported by evidence.

Evidence: Not supported

Gray hair, allergy relief, ADHD, general "wellness"

These uses are sometimes marketed but not supported by controlled-trial evidence. Be cautious of marketing claims that go beyond what research shows.

7. Top Food Sources

Key Takeaway

B5 is in nearly every food; the richest natural sources are beef liver, shiitake mushrooms, sunflower seeds, avocado, salmon, chicken, eggs, yogurt, and whole grains.

Because B5 is found in so many foods, most people get enough simply by eating a varied diet. Some of the richest natural sources: USDA FoodData Central. Pantothenic Acid content of foods (Standard Reference and Foundation Foods datasets). Open Source ↗ NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals — Sources of Pantothenic Acid section. Open Source ↗

Beef liver (3 oz cooked) — ~6 mg, about 120% of daily intake
Shiitake mushrooms (½ cup cooked) — ~2.6 mg, about 52%
Sunflower seeds (¼ cup) — ~2.3 mg, about 46%
Avocado (1 medium) — ~2.0 mg, about 40%
Yogurt, plain (1 cup) — ~1.4 mg, about 28%
Chicken breast (3 oz cooked) — ~1.3 mg, about 26%
Salmon or tuna (3 oz cooked) — ~1.0–1.4 mg, about 20–28%
Sweet potato (1 medium baked) — ~1.0 mg, about 20%
Whole wheat or brown rice (1 cup) — ~0.7–1.0 mg, about 14–20%
Egg (1 large) — ~0.7 mg, about 14%
Lentils, chickpeas (½ cup cooked) — ~0.5–0.7 mg, about 10–14%
Broccoli (½ cup cooked) — ~0.4 mg, about 8%

Note on food processing: Milling whole grains into white flour removes roughly 55% of the natural B5 in wheat and about 88% in maize. Choosing whole grains, when possible, preserves more of the vitamin. NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals — Sources section. Open Source ↗

Royal jelly (bee secretion) is the single richest natural source — about 511 µg per gram dry — but it isn't a practical everyday food and isn't recommended specifically for B5.

8. What Body Systems Does Vitamin B5 Support?

Key Takeaway

Because coenzyme A is involved in so many processes, virtually every body system depends on adequate B5 — especially energy metabolism, stress hormones, nervous system, skin, and liver fat handling.

Coenzyme A — the molecule your body makes from B5 — is involved in so many cellular processes that virtually every system relies on adequate B5: EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for pantothenic acid. EFSA Journal. 2014;12(2):3581. Authorized health claims (EU Reg 432/2012) for B5 role in energy metabolism, mental performance, steroid/vitamin D/neurotransmitter synthesis. Open Source ↗

⚡ Energy metabolism

B5 is needed to make coenzyme A, which sits at the center of how cells convert carbohydrates, fats, and protein into usable energy.

🧠 Nervous system

Supports the body's natural production of certain neurotransmitters, including acetylcholine.

🩺 Hormone production

Supports the body's natural production of steroid-type hormones, including stress hormones like cortisol.

🩹 Skin and tissues

Supports the body's natural skin barrier function and tissue repair processes — the basis for topical panthenol's use in wound and skin care.

🫀 Liver and lipid metabolism

Supports the body's natural processing of fats and cholesterol — the basis for pantethine's research on lipid markers.

🛡️ Immune function

Supports the body's natural antibody production processes.

9. Frequently Asked Questions

Key Takeaway

Answers to the most common B5 questions — covering safety, timing, form comparison, combinations, and diet — drawn from what people actually ask.

Is vitamin B5 the same as B-complex?

B5 is one of the eight B vitamins. A B-complex supplement contains all eight, including B5. If you're already taking a quality B-complex or multivitamin, you're likely getting enough B5.

If pantethine works for cholesterol, why doesn't regular B5?

Even though pantethine is closely related to pantothenic acid, your body breaks it down into a different compound called cysteamine — and cysteamine appears to be what produces the cholesterol effect. Regular B5 doesn't release cysteamine, so it doesn't produce the same result.

Does B5 affect lab tests?

Good news: unlike biotin (B7, which interferes with many common lab tests), vitamin B5 does NOT interfere with standard clinical lab tests. You don't need to stop B5 before a thyroid panel, troponin test, hormone test, or other routine blood work. U.S. Food and Drug Administration. The FDA warns that biotin may interfere with lab tests: FDA safety communication. November 2017. Biotin-streptavidin interference is specific to biotin (B7); pantothenic acid (B5) has no streptavidin-binding moiety. Open Source ↗

Can I just stop taking it?

Yes. There is no withdrawal effect, no rebound, and no required tapering schedule for vitamin B5 in any form. If you were taking pantethine for cholesterol, your cholesterol numbers will gradually return to baseline over a few weeks after stopping.

Is B5 safe for athletes who get drug-tested?

Yes — vitamin B5 is not on the WADA Prohibited List. To protect against contamination of the finished product, athletes may want to look for third-party-tested options.

How long until I notice anything?

For general nutrition, you wouldn't expect to "feel" anything specific — B5 just supports normal background metabolism. For pantethine on cholesterol, the relevant studies showed measurable changes at about 8 weeks and full effect at 16 weeks. For acne (high-dose protocol), the study used a 12-week timeline.

Can I take too much?

B5 has an unusually safe profile. The Institute of Medicine has not set an upper limit. Side effects at very high doses tend to be mild gastrointestinal discomfort (loose stools, stomach upset), usually only above 10 grams per day. Institute of Medicine. Dietary Reference Intakes 1998. No UL set due to insufficient evidence of harm. Open Source ↗

Does cooking destroy B5?

B5 is somewhat heat-sensitive, and prolonged high-temperature cooking (especially in water that you then discard) can reduce the amount in your food. Steaming, gentle simmering, and using cooking liquids in soups or sauces preserves more of it.

Should I take B5 with biotin or alpha-lipoic acid?

A B-complex multivitamin contains both B5 and biotin at standard doses and is fine. If you take high doses of any two of them — B5, biotin, and alpha-lipoic acid — separate them by 2–4 hours, because they share the same gut absorption pathway and can compete.

Does B5 help with stress or fatigue?

B5 is needed to make stress hormones, and you need adequate B5 for normal energy metabolism. But there's no strong evidence that taking extra B5 above the daily intake improves stress resilience or energy in people who already eat enough. The European food safety authority allows claims that B5 "contributes to the reduction of tiredness and fatigue" — that's about its role at normal nutritional levels, not a special effect from high doses. EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for pantothenic acid. EFSA Journal. 2014;12(2):3581. EU Reg 432/2012 authorized health claims. Open Source ↗

What's the difference between pantothenic acid, calcium pantothenate, pantethine, and panthenol?

Pantothenic acid is the chemical name. Calcium pantothenate is the most common, stable supplement form (in multivitamins). Pantethine is a different form that breaks down in the body to release cysteamine plus pantothenic acid — it's the form studied for cholesterol. Panthenol (or dexpanthenol) is the alcohol form used in skin creams. They're all related but not interchangeable for every use.

Can pregnant or breastfeeding women take B5?

Standard daily intake (6 mg/day during pregnancy in the US, 7 mg/day while breastfeeding) is well established and safe. Higher therapeutic doses during pregnancy and breastfeeding — such as pantethine for cholesterol — should be discussed with your healthcare provider. Institute of Medicine. Dietary Reference Intakes 1998. Open Source ↗

10. How to Choose a Quality Vitamin B5 Supplement — Bonus

Key Takeaway

The B5 supplement market is mature; match the form to your goal, look for transparent labeling, and watch out for marketing claims that go beyond the science.

The vitamin B5 supplement market is well-established and most reputable brands offer reliable products. A few practical pointers: NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals — Sources/Supplements section. Open Source ↗

Match the form to the goal

Calcium pantothenate is the everyday form for general nutrition. Pantethine is the form for cholesterol research-supported use. Panthenol is the form for skin creams. They're not interchangeable.

Look for transparent labeling

Milligrams clearly listed, batch numbers, expiration dates. Brand reputation: established companies generally manufacture under good manufacturing practice standards.

Cost expectations

Calcium pantothenate supplements are inexpensive — about $3–10 per month at typical doses. A multivitamin with B5 costs about $0.05–0.15 per day. Branded pantethine for cholesterol runs about $25–35 per month. Topical panthenol creams (like Bepanthen) run about $5–20 per tube.

Dietary preferences

If you have specific dietary needs (vegan, kosher, halal, allergen-free), check the product details — these certifications are commonly available for B5 from major manufacturers, since the vitamin itself can be made either by chemical synthesis or by microbial fermentation, both vegan-compatible.

Red flags

No clearly listed milligram amount; no expiration date; "miracle cure" or "instant energy" claims; promises of weight loss, hair regrowth, anti-aging effects, or athletic performance enhancement (none of which is supported by evidence for B5).

11. Your Genes & Vitamin B5 — Bonus

Key Takeaway

For almost everyone, no genetic testing is needed before taking B5; two very rare genetic conditions (PKAN and SMVT deficiency) need specialist care.

For the vast majority of people, no genetic testing is needed before taking B5. Two rare genetic conditions are worth knowing about for awareness:

PKAN (Pantothenate Kinase-Associated Neurodegeneration)

A very rare childhood-onset condition (about 1–3 per million people) where mutations in a gene called PANK2 disrupt the body's ability to use B5 to make coenzyme A. Specialist care from a pediatric neurology or NBIA clinic is essential. High-dose pantothenic acid is sometimes used in atypical adult-onset cases, but the evidence is anecdotal, and an experimental drug designed to bypass the defect (fosmetpantotenate) failed its Phase 3 trial. OMIM #234200: Neurodegeneration with Brain Iron Accumulation 1 (NBIA1/PKAN). Authoritative gene/disease entry. Open Source ↗ Bokhari SRA. StatPearls: Pantothenate Kinase-Associated Neurodegeneration (PKAN). NBK430689. Open Source ↗

SMVT Deficiency

An ultra-rare condition involving the gut transporter (SLC5A6) that brings B5 — along with biotin and alpha-lipoic acid — into the body. Combined high-dose supplementation of all three vitamins can help in these specific cases. About 10 families with this condition are known worldwide. Van Vyve C et al. JIMD Reports. 2024;65(1):28-37. PMID 38407570. Open Source ↗

For everyone else, there is no clinically meaningful pharmacogenomic test that should guide B5 dosing. The mainstream direct-to-consumer DNA tests that mention "B5 metabolism" are not validated for guiding supplementation decisions.

12. Traditional Roots — Bonus

Key Takeaway

Vitamin B5 itself is a 20th-century discovery, but foods rich in it — liver, brewer's yeast, royal jelly, whole grains — have long traditional-medicine histories.

Vitamin B5 as a named chemical is a 20th-century discovery — there's no pre-modern traditional-medicine use of "B5" because the concept didn't exist before 1933. But foods that turn out to be rich in B5 have long traditional-medicine histories: USDA FoodData Central. Pantothenic acid content of organ meats, brewer's yeast, royal jelly, whole grains. Open Source ↗

Liver and organ meats were prized across pre-modern cultures as restorative foods for recovery and convalescence — retrospectively, they're among the richest natural B5 sources.
Brewer's yeast and fermented foods have been used since antiquity as "tonics" or strengthening foods — they're now recognized as complete B-vitamin sources including B5.
Royal jelly (the bee secretion that feeds queen bees) has been used in traditional medicine across multiple cultures, especially in Chinese and Eastern European apitherapy. It happens to be the single richest natural B5 source (~511 µg/g dry), though royal jelly contains many other compounds too, so its traditional uses can't be cleanly attributed to B5 alone.
Pre-industrial whole grains preserved B5 content that modern milling removes. Traditional whole-grain diets meant higher B5 intake than today's refined-flour diets.

13. The Story Behind the Science — Bonus

Key Takeaway

Vitamin B5 was named "from everywhere" because it's in nearly every food; its quiet ubiquity is itself the story — no famous deficiency disease, just a steady role in turning food into energy.

Vitamin B5 is, in many ways, the quiet workhorse of the B-vitamin family. It doesn't get the headlines that B12 or folate get. It doesn't have a famous deficiency disease like scurvy (vitamin C) or beriberi (vitamin B1). But that quiet profile is itself a story.

The reason B5 doesn't have a famous deficiency disease is because the vitamin is so widely distributed in food that severe deficiency is genuinely rare. The reason it doesn't make headlines is because the daily nutritional dose is small (5 mg), the safety profile is excellent, and the major studied therapeutic uses — modest cholesterol improvement with pantethine, mild skin benefits with topical panthenol — are useful but not dramatic.

What B5 quietly does, every minute of every day, is provide the raw material your body uses to make coenzyme A — a molecule so essential that every living organism on earth uses it. The energy that powers your heart beating, your brain thinking, and your muscles moving all flows through coenzyme A.

Key Milestones

1931 — Roger Williams at the University of Texas isolates pantothenic acid as a yeast growth factor, naming it from the Greek pantothen ("from everywhere"). Williams RJ et al. J Am Chem Soc. 1933;55(7):2912-2927. Original isolation and naming paper. Open Source ↗
1941 — Researchers discover that royal jelly is the richest natural source of B5.
1947 — "Burning feet syndrome" in WWII Pacific-theater POWs is documented to respond to B-complex treatment that includes pantothenic acid.
1953 — Fritz Lipmann is awarded the Nobel Prize for discovering coenzyme A and showing how essential it is for metabolism. The Nobel Prize in Physiology or Medicine 1953 — Fritz Albert Lipmann "for his discovery of co-enzyme A and its importance for intermediary metabolism." Open Source ↗
1981–1991 — A cluster of Italian medical researchers conducts most of the early studies on pantethine for cholesterol, establishing the form's clinical reputation. McRae MP. Nutr Res. 2005;25(4):319-333. Pooled analysis of 28 studies, predominantly Italian. Open Source ↗
Mid-20th century onward — The topical B5 cream Bepanthen (Bayer) becomes a familiar pharmacy staple across Europe.
2014 — Evans and colleagues publish the most rigorous modern trial on pantethine for cholesterol; modest LDL effect confirmed. Evans M et al. Vasc Health Risk Manag. 2014;10:89-100. Open Source ↗
2019 — The FORT Phase 3 trial of fosmetpantotenate for PKAN fails its primary endpoint. Retrophin/Travere. Press release August 22, 2019. FORT Phase 3 NEGATIVE. Open Source ↗

The newer research story is about the differences between forms. Pantethine is closely related to pantothenic acid but, in the body, it splits into a different molecule (cysteamine) that gives it specific cholesterol-related effects. It's one of the cleaner examples in nutritional research of how chemical form really matters — two products that look almost identical on a supplement shelf can behave quite differently in the body.

14. Blood Tests That May Show Changes — Bonus

Key Takeaway

Routine B5 testing isn't done for most people; unlike biotin, B5 doesn't interfere with common lab tests, so you don't need to stop it before blood work.

For most people, no testing is needed. B5 deficiency is rare, and ordinary food is reliable enough that routine measurement isn't warranted.

For specific clinical situations, two lab measures exist:

Whole-blood pantothenate

Measures the total B5 carried inside red blood cells (the storage compartment). Normal range is roughly 1.6–2.7 micromoles per liter. This is the test that actually reflects nutritional status. NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet — Assessing Pantothenic Acid Status section. Open Source ↗

Urinary pantothenate

A 24-hour urine collection can reflect recent dietary intake, but is rarely done in routine practice.

Plasma (serum) B5 levels do not reliably reflect intake or body status, so a standard "B5 blood test" from regular blood work isn't typically informative. Specialty labs like SpectraCell offer broader micronutrient panels that include B5 if your healthcare professional thinks it's warranted.

One piece of good news worth repeating: vitamin B5 does not interfere with standard clinical lab tests (thyroid, cardiac troponin, hormones, vitamin panels, tumor markers, inflammatory markers) the way biotin (B7) can. If you're taking B5, you do not need to stop it before having lab work done. U.S. Food and Drug Administration. The FDA warns that biotin may interfere with lab tests: FDA safety communication. November 2017. Interference is specific to biotin (streptavidin-binding); B5 is unaffected. Open Source ↗

🟢 Last Reviewed: Thursday, May 21, 2026 · Next scheduled review: by Tuesday, August 19, 2026

Pantothenic Acid (Vitamin B5)

Clinical Decision Support Monograph

Clinician-facing technical reference: identification, mechanism, evidence, dosing, interactions, adverse effects, monitoring, contraindications

CLINICAL SUMMARY

Pantothenic Acid (Vitamin B5)

Water-soluble B-complex vitamin; precursor to coenzyme A (CoA) and acyl-carrier protein (ACP); central to mitochondrial fatty-acid oxidation, TCA cycle, steroidogenesis, neurotransmitter synthesis (acetylcholine), and hepatic lipid metabolism.

Overall Evidence

MODERATE

Primary Indications

STRONGDietary deficiency repletion · AI 5 mg/d adult; replacement reverses signs
MODERATEHyperlipidemia (pantethine only) · 600–900 mg/d × 16 wk; ~3–4% LDL-C reduction (Evans 2014 RCT)
LIMITEDAcne vulgaris (high-dose) · Yang 2014 RCT 2.2 g/d × 12 wk (P=0.0197); single positive trial, replication pending
MODERATETopical wound healing / mild AD (dexpanthenol) · 5% topical; CIR 2022 safety-as-used
LIMITEDPKAN — atypical adult-onset · consensus 250 mg→2–5 g/d; anecdotal; FORT Phase 3 of fosmetpantotenate NEGATIVE 2019
NULLAthletic performance · Studied — no benefit demonstrated

Standard Dose Range

Dietary: AI 5 mg/d adult (US IOM 1998, EFSA 2014); pregnancy 6 mg/d (US) or 5 mg/d (EU); lactation 7 mg/d; FDA DV 5 mg
Functional: 10–500 mg/d Ca-pantothenate (multivitamin / B-complex contexts); clinical-outcome benefit in replete adults [Not Characterized]
Pharmacological: Pantethine 600–900 mg/d × 16 wk (hyperlipidemia); Pantothenic acid 2.2 g/d × 12 wk (acne, Yang 2014); Ca-pantothenate 250 mg→2–5 g/d titrated (PKAN, specialist-coordinated); Dexpanthenol 5% topical (skin)

Key Safety Flags

🟢 STANDARD No UL set by IOM 1998 or EFSA 2014 (insufficient evidence of harm); mild GI >10 g/d
🟢 STANDARD NIH ODS Tier 1: "Pantothenic acid is not known to interact or interfere with any medicines"
🟠 CAUTION Pantethine mild antiplatelet effect; monitor INR on warfarin; hold 2 wk pre-procedure
🟠 CAUTION Rare Debourdeau 2001 case — elderly + high-dose B5 + high-dose biotin → eosinophilic pleuropericardial effusion (single case, not replicated)
🟢 STANDARD FDA Pregnancy Category A at AI level (Category C above-RDA); FDA GRAS 21 CFR 184.1212 for calcium pantothenate
🟢 STANDARD WADA 2026 Prohibited List: NOT listed (athlete-permitted)

Monitoring Quick-Ref

Whole-blood pantothenate: Normal 1.6–2.7 µmol/L; reflects nutritional status (CoA carried in RBCs)
Urinary pantothenate (24-hr): Reflects recent intake; rarely done clinically
Plasma pantothenate: Does NOT correlate with intake or body stores — clinically uninformative
Lipid panel: Baseline → wk 8 → wk 16 if pantethine initiated for hyperlipidemia
PKAN consensus dose: Specialist-coordinated; UPDRS / Fahn-Marsden per neurology follow-up

⚠️ Lab Interference

NONE documented for pantothenic acid. Sharply distinct from biotin (B7), which causes well-known streptavidin-biotin immunoassay interference (FDA Safety Communication 2017 ucm586505). Pantothenic acid has no streptavidin-binding moiety and does NOT interfere with thyroid (TSH/fT4/fT3), cardiac (troponin/NT-proBNP/CK-MB), reproductive hormones (FSH/LH/estradiol/progesterone/testosterone/hCG), stress-adrenal (cortisol/ACTH/aldosterone/DHEA-S), vitamin panels (B12/folate/25-OH vitamin D), tumor markers (PSA/CEA/CA125/CA19-9/AFP), inflammatory (hsCRP/IL-6/ferritin), or glycemic (HbA1c/insulin/C-peptide) immunoassays. Pre-test withdrawal NOT required. NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals. Open Source ↗

Clinical bottom line: Exceptionally clean safety profile (no UL set; no Tier 1 documented interactions per NIH ODS). Standard dietary needs met by ordinary diet (B5 in nearly every food). Pantethine ≠ pantothenic acid clinically — only pantethine produces lipid effects (cysteamine-mediated via VNN1 hydrolysis). Pharmacological-tier uses: pantethine for hyperlipidemia (modest ~3–4% LDL reduction; 16-week course); pantothenic acid 2.2 g/d for acne (single positive RCT, replication pending); high-dose Ca-pantothenate for atypical PKAN (anecdotal). FORT Phase 3 of fosmetpantotenate prodrug NEGATIVE (2019). No taper required on discontinuation. No lab interference (sharply distinct from biotin).

1. Drug Interactions

Key Takeaway

NIH ODS Tier 1 anchor: "Pantothenic acid is not known to interact or interfere with any medicines." Documented interactions are theoretical, pantethine-specific antiplatelet, or class-level B-complex timing (tetracyclines).

Tier 1 Anchor

NIH ODS framing: "Pantothenic acid is not known to interact or interfere with any medicines" NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals. Open Source ↗. Interactions documented below are theoretical, mechanism-suspected, or specific to the pantethine form rather than to dietary B5.

Supplement → Drug Direction

Drug class	Direction & Mechanism	Evidence	Clinical action
Warfarin / antiplatelet agents (aspirin, clopidogrel)	Pantethine has mild antiplatelet effect (Naumann 2024)	Tier 2 Naumann S et al. PMC11013948. 2024. Pantethine mild antiplatelet review. Open Source ↗	Monitor INR; advise surgical team if on pantethine ≥2 weeks pre-procedure
Cholinesterase inhibitors (donepezil, etc.)	Theoretical additive cholinergic effect (B5 → CoA → acetylcholine substrate)	Tier 3 Mechanism-only	Theoretical only; no clinical signal documented
Tetracyclines (B-complex co-administration)	General B-vitamin guidance: separate timing	Tier 3 Class-level	Take 2-3 hours apart from tetracycline

Drug → Nutrient Depletion (10-class systematic check)

Drug class	B5-specific depletion	Evidence
PPIs (omeprazole, pantoprazole, etc.)	Studied — Null	No documented B5-specific depletion
Metformin	Studied — Null	B12 depletion well-documented; B5-specific depletion NOT documented
Statins	Studied — Null	CoQ10 reduction documented; B5-specific depletion NOT documented
Antiepileptics (phenytoin, valproate)	Studied — Null	Folate/biotin depletion documented; B5 NOT documented
OCPs / hormonal contraceptives	Studied — Null	No B5-specific depletion documented
Loop / thiazide diuretics	Studied — Null	Thiamine depletion documented; B5 NOT documented
Broad-spectrum antibiotics (tetracyclines, fluoroquinolones)	Mechanism-supported	Modest reduction in microbial B5 contribution via colonic microflora disruption
Antineoplastics	Studied — Null	No B5-specific depletion documented
Glucocorticoids (long-term)	Studied — Null	No B5-specific depletion documented
ACE-I / ARBs	Studied — Null	No B5-specific depletion documented

2. Contraindications

Key Takeaway

Few absolute contraindications (hypersensitivity); pantethine + anticoagulants and elderly + high-dose B5+biotin combinations warrant caution. Pregnancy / lactation safe at dietary AI; Pharmacological-tier use should be discussed with provider.

2a — Absolute Contraindications

Known hypersensitivity to pantothenic acid, calcium/sodium pantothenate, pantethine, dexpanthenol, or excipients
Documented prior anaphylaxis to any B5 form

2b — Relative Contraindications & Cautions

Cardiovascular / hematologic

Concurrent warfarin or antiplatelet therapy with pantethine — monitor INR; advise surgical team
Scheduled invasive procedure within 2 weeks — discontinue pantethine; calcium pantothenate form does not require pre-procedure hold

Geriatric

Elderly patients (≥65) on high-dose B5 + high-dose biotin combination — Debourdeau 2001 caution applies Debourdeau PM et al. Ann Pharmacother. 2001;35(4):424-426. PMID 11302404. Open Source ↗

Pediatric / rare-disease

PKAN — specialist coordination essential (pediatric neurology / NBIA clinic); do not initiate or adjust dose unilaterally
SMVTD (biallelic SLC5A6 mutation) — triple-substrate rescue protocol must be physician-coordinated Van Vyve C et al. JIMD Reports. 2024;65(1):28-37. PMID 38407570. Open Source ↗

Pregnancy & Lactation

Tier	US (IOM 1998)	EU (EFSA 2014)	FDA Pregnancy Category
Pregnancy AI	6 mg/day	5 mg/day	Category A (at AI level)
Lactation AI	7 mg/day	7 mg/day	Category A (at AI level)
Pharmacological-tier (above AI)	No specific human-pregnancy/lactation trial data for pantethine 600–900 mg/d hyperlipidemia regimen or Yang 2014 acne 2.2 g/d regimen		Category C (above-RDA)

Dietary-tier use during pregnancy and lactation is well-established as safe (FDA Pregnancy Category A). For Pharmacological-tier indications (pantethine for hyperlipidemia, high-dose B5 for acne), no formal trials in pregnant or lactating populations have been published; Category C reflects absence of formal study rather than demonstrated risk. Discuss Pharmacological-tier use during pregnancy/lactation with the patient's healthcare provider. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press; 1998. Open Source ↗

2c — Pre-Treatment Clinical Assessment

Indication-confirmation: dietary deficiency rare; document the clinical rationale (hyperlipidemia, acne, PKAN, SMVTD, topical wound care)
Dose-tier selection: Dietary (5 mg/d AI), Functional (10-500 mg/d), Pharmacological (indication-specific)
Form selection: Ca-pantothenate (general); pantethine (lipid research); dexpanthenol (topical)
Concomitant medication review — anticoagulants/antiplatelets with pantethine; high-dose biotin co-administration
Baseline labs as clinically indicated (lipid panel for hyperlipidemia indication; ALT/AST baseline for long-term high-dose; whole-blood pantothenate if SMVTD suspected)

2d — On-Treatment Monitoring

Pantethine for hyperlipidemia: baseline lipid panel → week 8 recheck → week 16 endpoint assessment → continuation decision based on LDL-C response and tolerability
Pantothenic acid for acne (Yang 2014 protocol): baseline lesion count → 6-week assessment → 12-week endpoint assessment
PKAN consensus dose: specialist-coordinated; UPDRS / Fahn-Marsden scales per neurology follow-up schedule
Topical dexpanthenol: visual inspection of treatment area; contact dermatitis assessment
SMVTD triple-substrate rescue: specialist-coordinated; biotin, B5, α-lipoic acid serum levels per metabolic clinic protocol
All Pharmacological-tier: annual review of continued indication; routine clinical chemistry as needed (NOT affected by B5 — see §12)

3. Therapeutic Dosing

Key Takeaway

Three tiers: Dietary AI 5 mg/d; Functional 10–500 mg/d (no characterized clinical-outcome benefit in replete adults); Pharmacological indication-specific (pantethine 600–900 mg/d × 16 wk for lipids; 2.2 g/d × 12 wk for acne; 2–5 g/d Ca-pantothenate for PKAN). No UL.

Dietary Tier (Adequate Intake / DV)

Population	AI (US IOM 1998)	AI (EFSA 2014)	FDA Daily Value
Adult men & women	5 mg/day	5 mg/day	5 mg
Children 1-3 yr	2 mg/day	4 mg/day	—
Children 4-8 yr	3 mg/day	4 mg/day	—
Adolescents	4-5 mg/day	5 mg/day	—
Pregnancy	6 mg/day	5 mg/day	—
Lactation	7 mg/day	7 mg/day	—

Functional Tier (10–500 mg/day)

10-500 mg/day calcium pantothenate or B-complex; commonly included in multivitamins (typically 10 mg) and B-complex 50/100 products. Clinical-outcome benefit in replete adults: [Not Characterized] — no published RCT documents clinical-outcome benefit at this tier.

Pharmacological Tier — Indication-Specific Regimens

Indication	Form & Dose	Duration	Evidence	Risk profile
Hyperlipidemia adjunct	Pantethine 600 mg/d weeks 1-8 → 900 mg/d weeks 9-16 (Pantesin® branded recommended for clinical-trial-grade purity); 300 mg TID with meals	16 weeks	Tier 1 Evans 2014 / Rumberger 2011 triple-blind RCTs	Mild antiplatelet; discuss with surgical team if scheduled procedure
Acne vulgaris (Yang 2014 protocol)	2.2 g/day oral pantothenic-acid-based formulation; divided dosing (~800 mg TID or 550 mg QID with meals)	12 weeks	Tier 2 Single positive RCT	Mild GI at high dose; replication pending
PKAN — atypical adult-onset	Calcium pantothenate 250 mg → 2-5 g/day titrated	Months titration; long-term	Tier 2 Consensus anecdote	Specialist coordination essential
Topical dexpanthenol — wound healing / mild AD	5% topical cream/ointment, 1-3× daily	2-4 weeks per course	Tier 2 Multiple small RCTs	Rare contact dermatitis
Postop ileus stimulation	Dexpanthenol parenteral 250-500 mg IM/IV	Inpatient surgical setting	Tier 2 Limited modern RCT	Hospital-administered

Renal & Hepatic Impairment

Population	Dose adjustment	Clinical reasoning
Renal impairment (any eGFR stage, including CKD 3b, 4, 5, dialysis)	No adjustments provided in manufacturer's labeling for kidney disease Sanvictores T, Chauhan S. StatPearls: Vitamin B5 (Pantothenic Acid). NBK563233. Open Source ↗	Renally cleared as unchanged compound. Empiric practice: start at lower end of dose range in advanced CKD.
Hepatic impairment (any Child-Pugh class)	No adjustments provided in manufacturer's labeling for liver disease	Pantethine hydrolyzed by VNN1 primarily in liver. Theoretical concern in advanced hepatic impairment; no clinical data supports a specific Child-Pugh-based adjustment.
Dialysis	[Studied — Inconclusive]	B5 dialyzable as small water-soluble molecule. No formal post-dialysis re-dosing schedule documented.

Practical Administration & Tolerability

Practical question	Guidance
With food or empty stomach?	Take with food per StatPearls; improves GI tolerability at Pharmacological-tier doses
Divided dosing for 2.2 g/d acne protocol	800 mg TID or 550 mg QID with meals (vs single-dose) reduces bolus GI exposure
Divided dosing for pantethine 900 mg/d	300 mg TID with meals (most common trial dosing per McRae 2005)
Titration for high-dose acne	1.1 g/d for week 1, escalate to 2.2 g/d if tolerated — reduces premature discontinuation
Time-of-day	None established. No circadian-sensitive PK/PD considerations.

Bariatric Surgery & Malabsorption

Surgical procedure	B5-specific deficiency risk	Recommended supplementation
Roux-en-Y gastric bypass (RYGB)	Low Uncommonly observed Ganipisetti VM, Naha S. StatPearls: Bariatric Surgery Malnutrition Complications. NBK592383. "Pantothenic acid (vitamin B5) deficiency is uncommonly observed after bariatric surgery." Open Source ↗	Standard post-RYGB multivitamin (7.5-10 mg B5 typical, e.g., Centrum) adequate
Sleeve gastrectomy (SG)	Low Same as RYGB	Standard multivitamin protocol
Biliopancreatic diversion / duodenal switch (BPD/DS)	Possibly elevated Greater malabsorptive risk; no B5-specific data	Bariatric-specialty multivitamin recommended; empiric clinical monitoring
Short bowel syndrome / IBD with extensive resection	[Studied — Inconclusive]	Standard B-complex; specialty multivitamin if broader malabsorption documented

Cost & Accessibility

Form / Indication	Rx / OTC status	Monthly cost (USD, 2026)	Insurance
Calcium pantothenate (Dietary/Functional)	OTC; some Rx pharmacy databases list as generic ($4.58-7.25/30 × 500 mg via SingleCare)	$3-10/month at 250-500 mg/d	Typically not covered; HSA/FSA variable
Pantesin® branded pantethine	OTC dietary supplement only — NOT FDA-approved drug	$25-35/month branded; $15-25 generic	NOT covered for hyperlipidemia indication
PKAN consensus (2-5 g/d)	OTC; specialist-coordinated	$5-10/month bulk powder	NOT covered (off-label use)
Topical dexpanthenol (Bepanthen, etc.)	OTC; cosmetic positioning varies by country	$5-20 per tube	NOT typically covered

Tolerable Upper Intake Level (UL)

No UL set by IOM 1998 — insufficient evidence to define an upper limit. Mild GI effects (diarrhea, stomach discomfort) reported at >10 g/day. EFSA 2014 likewise did not set a UL. Institute of Medicine. Dietary Reference Intakes 1998. Open Source ↗

4. Clinical Evidence

Key Takeaway

Three States Rule: supportive (pantethine ~3-4% LDL reduction in Evans 2014; Yang 2014 acne RCT P=0.0197; Williams 1933 essentiality), null (athletic performance; PANK1/3/4 disease analog; common-variant PGx), and adverse (FORT Phase 3 NEGATIVE 2019; Hayflick 2020 PKAN pilot primary endpoint missed).

4A. Hyperlipidemia — Pantethine Form

Tier 1Studied — Modest effect Evans 2014 (triple-blind, placebo-controlled, n=32 randomized; 600 mg/day weeks 1-8 then 900 mg/day weeks 9-16, all on therapeutic lifestyle change diet) showed between-group LDL-C significance at week 8 (P=0.027) and week 16 (P=0.010); total cholesterol significance at week 16 (P=0.040); non-HDL-C significance at week 16 (P=0.042); apolipoprotein B 5% decrease from baseline Evans M et al. Vasc Health Risk Manag. 2014;10:89-100. Triple-blind placebo-controlled RCT. Open Source ↗. Companion sister-trial Rumberger 2011 (n=120, identical regimen) confirmed safety and showed similar sustained reductions Rumberger JA et al. Nutr Res. 2011;31(8):608-15. Open Source ↗. McRae 2005 DARE-quality systematic review (28 trials, n=646, median 900 mg/day, mean duration 12.7 weeks) reported larger magnitude reductions (LDL-C 20.1% at 4 months) but with methodological caveats — predominantly Italian, mostly small, often single-group baseline comparisons McRae MP. Nutr Res. 2005;25(4):319-333. DARE-quality systematic review. Open Source ↗. Dose escalation from 600 → 900 mg/day did not increase effect magnitude.

4B. PKAN (Pantothenate Kinase-Associated Neurodegeneration)

Tier 2 — Anecdotal / Single-arm Consensus high-dose calcium pantothenate (250 mg titrated to 2-5 g/day) for atypical PKAN is anecdote-based without controlled-trial confirmation. Hayflick 2020 pediatric pantethine pilot (open-label, n=15, 60 mg/kg/day × 24 weeks after 4-week titration from 20 mg/kg) did NOT achieve significant change in UPDRS I-III or Fahn-Marsden scores; rate-of-progression metrics showed slowing (UPDRS Z=2.614, P=0.009; FM Z=2.643, P=0.008); 4/15 (26.7%) evaluated "slightly improved" by blinded video Hayflick SJ et al. J Inherit Metab Dis. 2020;43(5):1144-1156. Single-arm open-label pilot. Open Source ↗.

FORT Phase 3 NEGATIVE (adverse finding — Three States Rule): Fosmetpantotenate (Retrophin/Travere) — a phosphopantothenate prodrug designed to bypass PANK2 deficiency — FAILED its primary endpoint (PKAN-Activities of Daily Living [PKAN-ADL] scale) and key secondary endpoints in the FORT Phase 3 trial Retrophin (now Travere Therapeutics). Press release August 22, 2019: FORT Phase 3 trial of fosmetpantotenate failed primary endpoint. Open Source ↗. The TIRCON2012V1 Phase 3 deferiprone iron-chelation trial similarly did not meet its primary BAD-scale endpoint, although exploratory analyses showed target engagement Klopstock T et al. Lancet Neurol. 2019;18(7):631-642. TIRCON Phase 3. Open Source ↗.

4C. Acne Vulgaris

Tier 2 — Single positive RCT, awaiting replication Yang 2014 randomized placebo-controlled trial (n=41 evaluable; pantothenic-acid-based dietary supplement 2.2 g/day × 12 weeks) showed significant reduction in total lesion count (P=0.0197) and inflammatory lesion count, with DLQI improvement Yang M et al. Dermatol Ther (Heidelb). 2014;4(1):93-101. Randomized placebo-controlled trial. Open Source ↗. Earlier open-label pilot (Capodice 2012, n=10) suggested sebum decline within 2-3 days and lesion regression beginning at 2 weeks. Replication of Yang 2014 in independent cohorts remains pending.

4D. Topical Dexpanthenol — Dermatological Applications

Tier 2 — Modest evidence base Multiple small-to-medium RCTs document modest benefit for wound healing, atopic dermatitis adjunct therapy, isotretinoin mucocutaneous side effects, and post-procedure soothing. Cosmetic Ingredient Review (CIR) Expert Panel 2022 safety assessment concluded panthenol and pantothenic acid derivatives are safe as used in cosmetics Scott LN et al. Int J Toxicol. 2022;41(2_suppl):77S-105S. CIR Expert Panel assessment. Open Source ↗. Prophylactic radiation-induced dermatitis prevention: Studied — Inconclusive/Possibly ineffective — outcome heterogeneous.

4E. Athletic Performance & Ergogenic Claims

Studied — Null (Three States Rule preserved) No controlled-trial evidence supports B5 supplementation enhancing athletic performance in well-trained athletes. Marketing claims for sports performance are not supported.

4F. Time-to-Effect Matrix

Indication	Regimen	First measurable change	Between-group significance	Full effect / Endpoint
Pantethine 600→900 mg/d hyperlipidemia	16 weeks (Evans 2014 / Rumberger 2011)	Week 4 (descriptive)	Week 8 LDL-C (P=0.027)	Week 16 (P=0.010 LDL-C; P=0.040 TC)
Pantothenic acid 2.2 g/d for acne (Yang 2014)	12 weeks	Sebum: 2-3 days (Capodice 2012 pilot)	Lesion count by week 8-12	Week 12 (P=0.0197)
Topical 5% dexpanthenol skin	2-4 weeks	Subjective: days	Epithelial repair 1-2 weeks	2-4 weeks course
PKAN consensus pantothenate	Months titration	[Not Characterized]	Rate-of-progression metrics only (Hayflick 2020)	UPDRS/FM not significantly changed in pilot
Functional-tier B5 in replete adults	—	[Not Characterized]	No published RCT	No published RCT

5. Adverse Effects

Key Takeaway

No UL; mild GI >10 g/d; pantethine mild antiplatelet effect; rare Debourdeau 2001 case (elderly + high-dose B5 + biotin → eosinophilic pleuropericardial effusion, single case, not replicated); FAERS/EudraVigilance/VigiBase show no withdrawal/rebound signal.

Common Adverse Effects (Very High Doses)

Mild GI: diarrhea, abdominal discomfort, nausea — typically at doses >10 g/day Institute of Medicine. Dietary Reference Intakes 1998. Mild GI effects at >10 g/day; no UL set due to insufficient evidence of harm. Open Source ↗
Mild headache (idiosyncratic)
Topical dexpanthenol: rare contact dermatitis (idiosyncratic) Scott LN et al. Int J Toxicol. 2022;41(2_suppl):77S-105S. CIR Expert Panel safety assessment. Open Source ↗

Pantethine-Specific

Mild antiplatelet effect at therapeutic dose (Naumann 2024) Naumann S et al. PMC11013948. 2024. Pantethine mild antiplatelet effect review. Open Source ↗
Modest GI tolerability superior to pantothenic-acid-free-acid at equimolar doses

Rare Serious Adverse Events

Debourdeau 2001 case report (PMID 11302404): elderly patient on high-dose pantothenic acid + biotin combination developed eosinophilic pleuropericardial effusion. Resolved on discontinuation. Single case report; no replication beyond original report Debourdeau PM et al. Ann Pharmacother. 2001;35(4):424-426. PMID 11302404. Open Source ↗. Caution warranted for elderly patients on high-dose B5 + high-dose biotin combinations.

Pharmacovigilance Surveillance (90-day refresh)

Database	Surveillance date	Withdrawal/rebound signal	Other safety signals
FDA FAERS / AEMS (US)	Thursday, May 21, 2026	NULL	None of clinical significance
EudraVigilance (EU EMA)	Thursday, May 21, 2026	NULL	None of clinical significance
WHO VigiBase	Thursday, May 21, 2026	NULL	None of clinical significance

Next mandatory check: by Tuesday, August 19, 2026 (90-day refresh).

Discontinuation Protocol

Withdrawal/rebound risk assessment

NULL No withdrawal, rebound, discontinuation syndrome, or dependence documented for any B5 form across FAERS, AEMS, EudraVigilance, or VigiBase pharmacovigilance surveillance.

Mechanistic basis for null withdrawal risk

No receptor occupancy or downregulation
Water-soluble vitamin — excess excreted unchanged in urine
CoA pool is normally regulated by feedback inhibition at PanK step; no rebound CoA depletion on B5 discontinuation
Tissue B5 stores deplete gradually over weeks if dietary intake drops below AI; no acute deprivation effect

Practical discontinuation guidance

Dietary / Functional tier: May be discontinued at any time without taper. Resume normal dietary intake.
Pantethine for hyperlipidemia: May be discontinued at any time. Lipid panel will gradually return to baseline over 4-8 weeks.
Pantothenic acid for acne (Yang 2014): May be discontinued at any time. No data on relapse trajectory post-discontinuation; clinical follow-up advised.
PKAN consensus dose: Specialist-coordinated. Consensus practice is continuation through life; do not unilaterally discontinue.
SMVTD triple-substrate rescue: Specialist-coordinated. Discontinuation requires metabolic clinic protocol.
Topical dexpanthenol: May be discontinued at any time without taper or rebound.

Clinician-initiated discontinuation criteria

Therapeutic failure: lack of measurable LDL-C response by week 16 (pantethine); lack of lesion reduction by week 12 (acne protocol)
Tolerability failure: persistent GI effects at lowest effective dose
New contraindication: scheduled invasive procedure (pantethine 2-week hold); new anticoagulant initiation
Adverse event: contact dermatitis (topical); rare systemic reaction

6. Mechanism of Action

Key Takeaway

B5 → 5-step CoA biosynthesis (PanK1/2/3/4 rate-limiting); SMVT (SLC5A6) co-transports B5/biotin/α-lipoic acid; pantethine hydrolyzed by VNN1 to cysteamine + B5 — cysteamine, not B5, mediates pantethine's lipid effects.

Coenzyme A Biosynthesis (5-step pathway)

Pantothenate → 4′-phosphopantothenate (PanK1/2/3/4; rate-limiting) → 4′-phosphopantothenoylcysteine (PPCS) → 4′-phosphopantetheine (PPCDC) → dephospho-CoA (PPAT) → CoA (DPCK) Leonardi R et al. Prog Lipid Res. 2005;44(2-3):125-53. CoA biosynthesis review. PMID 15893380. Open Source ↗. PanK2 is the mitochondrial isoform critical in CNS; PANK1/3/4 are cytosolic isoforms with biological redundancy. PANK3 carries strongest CoA-acyl feedback inhibition (IC50 ~1-2 µM).

SMVT (SLC5A6) Transport

Sodium-Dependent Multivitamin Transporter — 12-transmembrane plasma membrane protein; Km for pantothenate ~10-20 µM; co-transports biotin (B7), pantothenic acid (B5), and α-lipoic acid via sodium-coupled active transport Vadlapudi AD et al. Curr Drug Targets. 2012;13(7):994-1003. SMVT review. PMC4406285. Open Source ↗. Competition at SMVT is the basis for the B5 ↔ biotin ↔ α-lipoic acid stacking caution at high doses.

Pantethine → Cysteamine Release (VNN1 pantetheinase)

Vanin-1 (VNN1; EC 3.5.1.92; UniProt O95497) is the GPI-anchored cell-surface amidohydrolase that hydrolyzes pantetheine → cysteamine + pantothenic acid (RHEA:13445). Tissue expression: liver > intestine > kidney > thymus; transcriptionally regulated by PPAR-α and inflammatory cytokines. The cysteamine released by VNN1 hydrolysis — not the pantothenic acid moiety — appears to mediate pantethine's lipid effects through proposed inhibition of acetyl-CoA carboxylase and modulation of hepatic cholesterol synthesis McCarty MF. Med Hypotheses. 2001;56(3):314-7. Cystamine/cysteamine mechanism hypothesis. PMID 11359352. Open Source ↗.

7. Pharmacokinetics (ADME)

Key Takeaway

SMVT-mediated saturable absorption (Km ~10-20 µM); ~75-80% B5 in erythrocytes as bound CoA (plasma B5 does NOT correlate with intake); renal excretion unchanged; pantethine PK distinct via VNN1 hydrolysis to cysteamine + 2× pantothenic acid.

Parameter	Value
Absorption — food matrix	~40-61% in mixed diet (Cheng 1988); food-bound B5 must be released by digestive enzymes before SMVT uptake
Absorption — supplemental free acid / Ca-pantothenate	Saturable SMVT-mediated active transport at low doses; passive diffusion contributes at high doses
Primary transporter	SMVT (SLC5A6); Km ~10-20 µM
Plasma vs whole-blood distribution	~75-80% in erythrocytes (as bound CoA); plasma does NOT correlate with intake or body stores
Whole-blood pantothenate (normal range)	1.6-2.7 µmol/L
Tissue distribution	Highest in liver, adrenal cortex, heart, kidney (CoA-rich tissues)
Metabolism	Incorporated into CoA pool; CoA half-life varies by tissue (~hours to days); deacylation by intracellular acyl-CoA hydrolases
Excretion	Renal — unchanged pantothenate in urine; reflects recent intake more than body stores
Pantethine PK distinction	Hydrolyzed by VNN1 at gut/liver brush border → cysteamine + 2× pantothenic acid; cysteamine mediates lipid effects
Blood-brain barrier	Pantothenic acid crosses via SMVT-mediated brain capillary endothelium transport Uchida Y et al. Mol Pharm. 2015;12(7):2548-56. PMID 25809983. Open Source ↗. Pantethine does NOT efficiently cross BBB.

8. Pharmacogenomics & Genetics

Key Takeaway

PANK2 (PKAN diagnostic), SLC5A6 (SMVTD diagnostic), VNN1 (research-only) are the clinically-relevant genes; no general-population PGx test recommended for routine B5 use. PANK1/3/4 redundant — no disease analog.

Gene	OMIM	Disease / Function	Clinical PGx implication
PANK2	#234200	Mitochondrial pantothenate kinase; PKAN/NBIA1 (prevalence ~1-3 per million)	Sequencing diagnostic gold standard for PKAN. Consensus pantothenate 250 mg → 2-5 g/day in atypical adult-onset cases (anecdote-based). FORT Phase 3 of phosphopantothenate prodrug NEGATIVE. OMIM #234200: Neurodegeneration with Brain Iron Accumulation 1 (NBIA1) — pantothenate kinase-associated neurodegeneration. Open Source ↗ OMIM #606157: PANK2 — pantothenate kinase 2 gene. Chromosome 20p13. Open Source ↗ Bokhari SRA. StatPearls: Pantothenate Kinase-Associated Neurodegeneration (PKAN). NBK430689. Open Source ↗
PANK1, PANK3, PANK4	—	Cytosolic pantothenate kinase isoforms	Studied — Null No human disease analog to PKAN. PANK3 has strongest acetyl-CoA feedback inhibition.
SLC5A6	#618973	SMVT transporter; biallelic mutations → SMVTD (combined biotin + B5 + α-lipoic acid deficiency)	Sequencing for SMVTD diagnosis only. ~10 families worldwide; one Algerian/Maghreb consanguineous cluster. Triple-substrate rescue protocol per Van Vyve 2024. Van Vyve C et al. JIMD Reports. 2024;65(1):28-37. PMID 38407570. SMVTD triple-substrate rescue protocol. Open Source ↗ Studied — Null for common-variant effects in general population.
VNN1	—	Pantetheinase (EC 3.5.1.92); GPI-anchored amidohydrolase	Mediates pantethine → cysteamine release. Research-only; no CPIC or DPWG guideline endorses VNN1 genotyping for pantethine dosing.
VNN2 (GPI-80)	—	Neutrophil pantetheinase	Functional in immune-cell migration/adhesion
VNN3	—	Smallest paralog; frame-shifted in humans	Less characterized; nine splice variants identified in neutrophils
PPCS, PPCDC, PPAT, DPCK	—	Downstream CoA biosynthesis enzymes	PPCS biallelic mutations → ultra-rare dilated cardiomyopathy (Iuso 2018). Otherwise no common PGx dosing implication.

Clinical PGx recommendation: NONE for general-population pantothenic acid use. PANK2 sequencing for PKAN diagnosis only; SLC5A6 sequencing for SMVTD diagnosis only; VNN1 genotyping is research-only.

9. Chemical Identity & Forms

Key Takeaway

C₉H₁₇NO₅ (MW 219.24); D-isomer only is bioactive (specific rotation +25.0° to +27.5° per USP); five commercial forms (free acid, Ca-pantothenate, Na-pantothenate, dexpanthenol, pantethine) — clinically distinct, especially pantethine for lipid effects.

Parameter	Value
IUPAC name	3-[(2R)-2,4-Dihydroxy-3,3-dimethylbutanamido]propanoic acid
CAS Registry (free acid)	79-83-4
CAS Registry (calcium D-pantothenate)	137-08-6
Molecular formula (free acid)	C₉H₁₇NO₅
Molecular weight (free acid)	219.24 g/mol
Molecular formula (Ca-pantothenate)	(C₉H₁₆NO₅)₂Ca; MW 476.53
Active enantiomer	D-isomer (dextrorotatory) only; specific rotation +25.0° to +27.5° per USP
Pharmacopeial standards	USP-NF M11910; Ph. Eur.; JP; ChP; FCC 3rd Ed. (1981) p.56
FDA GRAS	21 CFR 184.1212 for calcium pantothenate as nutrient supplement, no limit other than cGMP

Commercial Forms

Form	Use case	Distinguishing feature
D-Pantothenic acid (free acid)	Some supplement formulations	Less stable than salts
Calcium D-pantothenate	Dominant supplement & food fortification form	Most stable; FDA GRAS 21 CFR 184.1212
Sodium D-pantothenate	Some parenteral formulations	Sodium-salt option
D-Panthenol / dexpanthenol	Topical cosmetic; parenteral postop ileus	Alcohol analog; in vivo converted to B5
Pantethine	Cholesterol-research form	Two pantothenic acid moieties linked via disulfide; in vivo hydrolyzed by VNN1 to release cysteamine + 2× pantothenic acid

Critical clinical distinction: Pantethine ≠ pantothenic acid for lipid effects. Per NIH ODS Tier 1 framing, pantothenic acid itself does not reproduce pantethine's cholesterol-lowering effects. The lipid effect appears mediated by cysteamine, the cleavage product released when VNN1 hydrolyzes pantethine in vivo.

Regulatory Status — Summary

Jurisdiction / Framework	Status
FDA GRAS (US)	21 CFR 184.1212 — calcium pantothenate as direct food substance, no limit beyond cGMP eCFR 21 CFR 184.1212. Open Source ↗
FDA DSHEA (US)	All B5 forms qualify as dietary ingredients; structure-function claims permitted with disclaimer; disease claims prohibited
FDA Pregnancy Category	A (at AI level); C (above-RDA Pharmacological tier)
EU EFSA	NDA Panel Scientific Opinion 2014 sets AI 5 mg/d adults; EU Reg 432/2012 authorized health claims for normal energy-yielding metabolism, mental performance, steroid/Vitamin D/neurotransmitter synthesis, tiredness/fatigue reduction
WADA 2026 Prohibited List	NOT listed (athlete-permitted in and out of competition)
Animal feed (AAFCO / EU Reg 1831/2003)	Calcium D-pantothenate authorized; ~80% of ~6,000 tons/year global production
Cosmetic (CIR Expert Panel 2022)	Panthenol and pantothenic acid derivatives safe as used

10. Organ System Effects

Key Takeaway

CoA-dependent across virtually all systems; clinically prominent in hepatic lipid metabolism (pantethine cysteamine pathway), adrenal steroidogenesis (EFSA-authorized claim), CNS (PANK2 / PKAN), and integumentary (topical dexpanthenol).

System	Mechanistic role	Clinical relevance
Hepatic / Lipid metabolism	CoA → acyl-CoA → fatty acid β-oxidation, cholesterol biosynthesis, ketogenesis; ACP component of fatty acid synthase	Pantethine → cysteamine reduces hepatic acetyl-CoA carboxylase activity (proposed mechanism for lipid effects); CoA-dependent acyl-CoA esterification regulates VLDL secretion
Adrenal cortex / Endocrine	CoA-dependent steroidogenesis: pregnenolone → progesterone → cortisol / aldosterone / sex steroid pathways all require CoA-acyl intermediates	EFSA-authorized claim: "contributes to normal synthesis and metabolism of steroid hormones." Clinical "adrenal support" supplementation effect in replete adults not established. EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for pantothenic acid. EFSA Journal. 2014;12(2):3581. EU Reg 432/2012 authorized health claims for steroid hormone synthesis. Open Source ↗
CNS / Nervous system	CoA precursor for acetylcholine synthesis (acetyl-CoA + choline → acetylcholine + CoA-SH); PANK2-mediated mitochondrial CoA pool critical for globus pallidus iron homeostasis	PKAN: PANK2 loss-of-function → globus pallidus iron accumulation, "eye-of-the-tiger" MRI sign, dystonia. Historical "burning feet syndrome" (Glusman 1947) responded to B-complex including B5. Bokhari SRA. StatPearls: PKAN. NBK430689. "Eye-of-the-tiger" sign and globus pallidus iron pathology. Open Source ↗
Cutaneous / Integumentary	CoA-dependent ceramide and barrier-lipid synthesis; dexpanthenol acts as humectant + epithelial-repair stimulant	Topical dexpanthenol modest wound healing, mild AD adjunct benefit (CIR 2022) Scott LN et al. Int J Toxicol. 2022;41(2_suppl):77S-105S. CIR Expert Panel safety assessment. Open Source ↗
Hematological	CoA participates in heme biosynthesis (δ-ALA synthase pathway). VNN2 (GPI-80) expressed in neutrophils.	Routine B5 levels not clinically monitored. Pantethine mild antiplatelet effect documented in vitro/preclinical.
Renal	SMVT (SLC5A6) expressed in renal proximal tubule for vitamin reabsorption	Excess B5 excreted unchanged in urine
GI / Microbiota	Colonic microbiota produces small amounts of B5; SMVT-mediated absorption in small intestine	Long-term broad-spectrum antibiotics may modestly reduce microbial B5 contribution (mechanism-supported)

11. Co-Prescribing & Synergy

Key Takeaway

Positive synergies (B-complex, SMVTD triple-substrate rescue) and SMVT-competition caveats at Pharmacological-tier (B5 ↔ biotin ↔ α-lipoic acid; separate by 2-4 h at high doses).

Positive Synergies

B-complex co-supplementation — mechanistically supported (B1/B2/B3/B5/B6/B7/B9/B12 all participate in interconnected one-carbon and CoA-dependent pathways); outcome benefit in replete adults not characterized by RCT
Pantethine + Co-Q10 + B2 + B3 + PLC stack — Bonomi 2002 rat hyperlipidemia model showed additive lipid-lowering effect
Pantothenic acid + biotin + α-lipoic acid combined high-dose — rescue protocol for SMVTD (Van Vyve 2024)

Negative Stacking — SMVT Competition

At Pharmacological-tier doses, pantothenic acid (B5), biotin (B7), and α-lipoic acid all share the SMVT transporter Vadlapudi AD et al. Curr Drug Targets. 2012;13(7):994-1003. PMC4406285. Open Source ↗Chirapu SR et al. Curr Top Med Chem. 2013;13(7):837-42. PMID 23578027. SMVT specificity. Open Source ↗. Concurrent high-dose co-administration may reduce mutual absorption.

Practical recommendation: When taking high-dose B5 with high-dose biotin or α-lipoic acid (e.g., >100 mg/day each), separate doses by 2-4 hours to mitigate SMVT competition.

12. Lab Monitoring & Lab Interference

Key Takeaway

Whole-blood pantothenate 1.6-2.7 µmol/L for status (plasma uninformative). NO lab interference for B5 — sharply distinct from biotin (B7), which causes well-known streptavidin-biotin immunoassay interference.

Status Markers

Marker	Method	Normal range	Clinical utility
Whole-blood pantothenate	Microbiological assay (Pelczar & Porter 1941 Proteus morganii) or HPLC	1.6-2.7 µmol/L	Reflects nutritional status; CoA carried in RBCs NIH Office of Dietary Supplements. Pantothenic Acid Fact Sheet — Assessing Pantothenic Acid Status. Open Source ↗
Urinary pantothenate (24-hr)	HPLC / mass spectrometry	Variable, intake-dependent	Reflects recent intake; rarely done clinically
Plasma pantothenate	HPLC	Variable	Does NOT correlate with intake or body stores — clinically uninformative
Specialty micronutrient panels	SpectraCell MNT (intracellular B5 in lymphocytes); Genova NutrEval; Vibrant America	Lab-specific reference	Available but routine clinical use limited

Lab Interference — 8-Panel Systematic Check

Critical clinical distinction: Unlike biotin (B7, which famously interferes with streptavidin-biotin immunoassays per FDA Safety Communication 2017 ucm586505 and AACC 2018 Guidance), pantothenic acid does NOT contain streptavidin-binding moiety and does NOT interfere with any standard clinical chemistry immunoassays. U.S. FDA. Update: The FDA Warns that Biotin May Interfere with Lab Tests. FDA Safety Communication, November 2017 (ucm586505). Interference confined to biotin via streptavidin binding. Open Source ↗ AACC/ADLM Academy Guidance Document on Biotin Interference in Laboratory Tests. 2019. Confirms B5 is not implicated. Open Source ↗

Panel	B5 interference	Evidence
Thyroid (TSH, fT4, fT3, TgAb, TPOAb)	NEGATIVE	No streptavidin-binding moiety
Cardiac (troponin I/T, NT-proBNP, CK-MB)	NEGATIVE	No streptavidin-binding moiety
Reproductive hormones (FSH, LH, estradiol, progesterone, testosterone, hCG)	NEGATIVE	No streptavidin-binding moiety
Stress/Adrenal (cortisol, ACTH, aldosterone, DHEA-S)	NEGATIVE	No streptavidin-binding moiety
Vitamin panels (B12, folate, 25-OH vitamin D)	NEGATIVE	No streptavidin-binding moiety
Tumor markers (PSA, CEA, CA125, CA19-9, AFP)	NEGATIVE	No streptavidin-binding moiety
Inflammatory (hsCRP, IL-6, ferritin)	NEGATIVE	No streptavidin-binding moiety
Glycemic (HbA1c, insulin, C-peptide)	NEGATIVE	No streptavidin-binding moiety

Pre-test withdrawal: NOT required for B5 — patients on any B5 form may have routine clinical chemistry without holding the supplement.

13. Traditional Medicine & Historical Context

Key Takeaway

20th-century scientific discovery (Williams 1931); royal jelly is richest natural source (Pearson & Burgin 1941); Lipmann 1950s Nobel Prize for CoA; Italian pantethine clinical-research cluster 1981-1991.

Year	Milestone
1931-1933	Williams (Univ. Texas at Austin) isolates pantothenic acid as yeast growth factor; formal characterization J Am Chem Soc 55:2912. Named from Greek "pantothen" — from everywhere. Williams RJ et al. J Am Chem Soc. 1933;55(7):2912-2927. Original isolation. Open Source ↗
Late 1930s	Elvehjem & Jukes demonstrate "anti-dermatitis factor" function in chickens.
1941	Pelczar & Porter microbiological assay (Proteus morganii) establishes quantitative status assessment. Pearson & Burgin discover royal jelly as richest natural source (~511 µg/g dry basis).
1947	Glusman documents "burning feet syndrome" in WWII Pacific-theater Allied POWs responsive to B-complex including B5 (Am J Med 3:211-23).
1953	Fritz Lipmann awarded Nobel Prize for discovery of coenzyme A. The Nobel Prize in Physiology or Medicine 1953 — Fritz Albert Lipmann "for his discovery of co-enzyme A and its importance for intermediary metabolism." Open Source ↗
Mid-1960s	Pantothenic acid identified as acyl carrier protein (ACP) component in fatty acid synthase complex.
1981-1991	Italian clinical-research cluster (Sirtori et al., Univ. Milan) conducts 28 pantethine hyperlipidemia trials; pooled by McRae 2005.
Mid-20th century onward	Bayer Bepanthen® establishes European dexpanthenol cosmetic/pharmaceutical tradition.
2000s onward	Chinese manufacturers (Xinfa, Hubei Yihua) dominate global calcium pantothenate supply (~6,000 tons/year; ~80% animal feed).
2014	Evans 2014 publishes most rigorous modern pantethine hyperlipidemia RCT; modest LDL effect confirmed.
2019	FORT Phase 3 trial of fosmetpantotenate in PKAN — NEGATIVE.
2020	Hayflick PKAN pediatric pantethine pilot — primary endpoint not met; rate-of-progression slowing only.

Royal jelly historical attribution: although richest natural B5 source by far, royal jelly's reported therapeutic properties cannot be cleanly attributed to its B5 content — whole-product confounding (MRJP proteins, 10-HDA, other B-vitamins) preserved.

14. Quality Control

Key Takeaway

USP-NF M11910 specifications for Ca-pantothenate (98-102% assay, +25.0° to +27.5° specific rotation, β-alanine ≤1.0%); two manufacturing routes (dominant chemical synthesis; emerging microbial fermentation); Pantesin® branded pantethine = trial-grade form.

USP-NF Calcium Pantothenate (M11910) Specifications

The United States Pharmacopeia monograph for calcium pantothenate establishes the following identity, assay, and impurity specifications: USP-NF Monograph: Calcium Pantothenate (M11910). Calcium salt of dextrorotatory isomer of pantothenic acid; assay 98.0-102.0%; specific rotation +25.0° to +27.5°. Open Source ↗ eCFR 21 CFR 184.1212 — Calcium pantothenate GRAS for use as direct food substance, no limit beyond cGMP. Open Source ↗

Parameter	Specification
Assay (current USP-NF)	98.0-102.0% calcium pantothenate (dried basis)
Nitrogen content	5.7-6.0%
Calcium content	8.2-8.6%
Specific rotation (D-isomer)	+25.0° to +27.5°
β-Alanine impurity limit	≤1.0% (synthesis-route impurity)
Identification A	IR matching USP Calcium Pantothenate RS
Heavy metals	Per USP <231>
Residual solvents / OVI	Per USP <467>

Manufacturing Routes

Chemical synthesis (dominant): D-pantolactone + β-alanine via aldol chemistry; cyanide environmental-stress driver; optical resolution required from racemic intermediate
Microbial fermentation (emerging, minority share): engineered E. coli / C. glutamicum / S. cerevisiae from glucose substrate; Zou 2021 peak titer 68.3 g/L in 5L fermenter; not yet cost-competitive with chemistry per Reddy 2024

Pantesin® Branded Pantethine

Kyowa Hakko Bio (Japan) is the dominant pharmaceutical-grade pantethine supplier; Pantesin® is the trial-grade form used in Rumberger 2011 and Evans 2014 RCTs. For Pharmacological-tier therapeutic use, Pantesin branding is recommended for clinical-trial-grade purity assurance.

🟢 Last Reviewed: Thursday, May 21, 2026 · Next scheduled review: by Tuesday, August 19, 2026

Your cart is empty

Pantothenic Acid (Vitamin B5)

1. What Is Vitamin B5?

Key Highlights

2. Signs You May Be Running Low

3. Who Should Be Careful or Avoid

Who Should Talk to a Healthcare Provider First

Timing Notes for Other Supplements and Medications

4. How to Get the Best Results

Daily Intake

When and How to Take It

Take with food

Divide higher doses

Separate from high-dose biotin or alpha-lipoic acid

No taper needed when stopping

Choosing the Right Form for Your Goal

For general nutrition

For cholesterol research-supported use

For skin application

Time to See an Effect

5. Side Effects to Know About

Mild Effects (Usually Only at Very High Doses)

Pantethine-Specific

One Rare Serious Case to Know About

Withdrawal or Rebound

6. What Research Suggests

Daily dietary need (5 mg/day)

Cholesterol — pantethine 600–900 mg/day for 16 weeks

Acne — high-dose B5 (2.2 g/day for 12 weeks)

Skin care creams — topical panthenol / dexpanthenol

PKAN — very rare genetic condition

Athletic performance

Gray hair, allergy relief, ADHD, general "wellness"

7. Top Food Sources

8. What Body Systems Does Vitamin B5 Support?

⚡ Energy metabolism

🧠 Nervous system

🩺 Hormone production

🩹 Skin and tissues

🫀 Liver and lipid metabolism

🛡️ Immune function

9. Frequently Asked Questions

10. How to Choose a Quality Vitamin B5 Supplement — Bonus

Match the form to the goal

Look for transparent labeling

Cost expectations

Dietary preferences

Red flags

11. Your Genes & Vitamin B5 — Bonus

PKAN (Pantothenate Kinase-Associated Neurodegeneration)

SMVT Deficiency

12. Traditional Roots — Bonus

13. The Story Behind the Science — Bonus

Key Milestones

14. Blood Tests That May Show Changes — Bonus

Whole-blood pantothenate

Urinary pantothenate